home / stock / hbpcf / hbpcf news

HBPCF News and Press, Helix Biopharma Corp From 12/14/23

Stock Information
Company Name: Helix Biopharma Corp
Stock Symbol: HBPCF
Market: OTC
Website: helixbiopharma.com
Menu
HBPCF HBPCF Quote HBPCF Short HBPCF News HBPCF Articles HBPCF Message Board
Get HBPCF Alerts

News, Short Squeeze, Breakout and More Instantly...
HBPCF - Helix Biopharma GAAP EPS of -$0.01

2023-12-14 17:08:28 ET More on Helix Biopharma Financial information for Helix Biopharma For further details see: Helix Biopharma GAAP EPS of -$0.01
HBPCF - Helix BioPharma Corp. Announces Fiscal 2024 First Quarter Results

--News Direct-- Toronto, Ontario – TheNewswire – December 14, 2023 – Helix BioPharma Corp. (TSX:HBP), (“Helix” or the “Company”), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology based o...

HBPCF - Expected US Company Earnings on Wednesday, December 13th, 2023

Epiroc AB ADR (EPOKY) is expected to report for Q3 2023 Sysmex Corporation ADR (SSMXY) is expected to report for Q2 2024 Streamline Health Solutions Inc. (STRM) is expected to report for Q1 2024 Helix Biopharma Corp. (HBPCF) is expected to report for Q2 2024 Standard Chartered plc...

HBPCF - Expected earnings - Helix Biopharma Corp.

Helix Biopharma Corp. (HBPCF) is expected to report for Q2 2024
HBPCF - Helix Biopharma GAAP EPS of -C$0.03

2023-10-27 17:35:33 ET More on Helix Biopharma Financial information for Helix Biopharma For further details see: Helix Biopharma GAAP EPS of -C$0.03

HBPCF - Helix Biopharma Corp. Announces Fiscal 2023 Year-End Results

(TheNewswire) Toronto, Ontario - TheNewswire - October 27, 2023 - Helix BioPharma Corp. (TSX:HBP) , (“ Helix ” or the “ Company ”), a clinical-stage biopharmaceutical company developing unique therapies in the field of immu...

HBPCF - Helix Biopharma Announces Upcoming Poster Presentation at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

--News Direct-- Toronto, Ontario - TheNewswire - October 10, 2023 - Helix BioPharma Corp. (TSX:HBP) (“Helix” or the “Company”), an immune-oncology antibody-drug-conjugate company developing an innovative drug platform for the treatment of cancer, announced today th...
HBPCF - Helix BioPharma Corp. Announces Closing of Private Placement of CAD $3 Million and Board Changes

(TheNewswire) Toronto, Ontario - TheNewswire - August 22, 2023 - Helix BioPharma Corp. (TSX:HBP) (“ Helix ” or the “ Company ”), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology...

HBPCF - Helix Biopharma GAAP EPS of -C$0.01

2023-06-14 17:17:54 ET Helix Biopharma press release ( OTCPK:HBPCF ): Q3 GAAP EPS of -C$0.01. For further details see: Helix Biopharma GAAP EPS of -C$0.01

HBPCF - Helix BioPharma Corp. Announces Fiscal 2023 Third Quarter Results

--News Direct-- Toronto, Ontario – TheNewswire – June 14, 2023 - Helix BioPharma Corp. (TSX:HBP), (“Helix” or the “Company”), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology based on its propr...
Previous 10 Next 10